RT-PCR analysis demonstrated that the metastatic tumors exhibited higher levels of AKR1C1 mRNA compared with the primary sites (P = 0.008; Supplementary Fig. 6). This evidence concerns the gene AKR1C1 and metastatic neoplasm.